CRSP
Price
$41.51
Change
+$0.98 (+2.42%)
Updated
Jan 21 closing price
Capitalization
3.54B
27 days until earnings call
KYMR
Price
$43.70
Change
+$3.09 (+7.61%)
Updated
Jan 21 closing price
Capitalization
2.83B
29 days until earnings call
Ad is loading...

CRSP vs KYMR

Header iconCRSP vs KYMR Comparison
Open Charts CRSP vs KYMRBanner chart's image
CRISPR Therapeutics AG
Price$41.51
Change+$0.98 (+2.42%)
Volume$1.81M
Capitalization3.54B
Kymera Therapeutics
Price$43.70
Change+$3.09 (+7.61%)
Volume$454.3K
Capitalization2.83B
CRSP vs KYMR Comparison Chart
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRSP vs. KYMR commentary
Jan 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a Hold and KYMR is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 22, 2025
Stock price -- (CRSP: $41.51 vs. KYMR: $43.70)
Brand notoriety: CRSP and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 99% vs. KYMR: 91%
Market capitalization -- CRSP: $3.54B vs. KYMR: $2.83B
CRSP [@Biotechnology] is valued at $3.54B. KYMR’s [@Biotechnology] market capitalization is $2.83B. The market cap for tickers in the [@Biotechnology] industry ranges from $341.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, KYMR is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 5 TA indicator(s) are bullish while KYMR’s TA Score has 3 bullish TA indicator(s).

  • CRSP’s TA Score: 5 bullish, 2 bearish.
  • KYMR’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, CRSP is a better buy in the short-term than KYMR.

Price Growth

CRSP (@Biotechnology) experienced а +8.21% price change this week, while KYMR (@Biotechnology) price change was +8.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.46%. For the same industry, the average monthly price growth was +2.44%, and the average quarterly price growth was -0.23%.

Reported Earning Dates

CRSP is expected to report earnings on May 12, 2025.

KYMR is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (+2.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($3.54B) has a higher market cap than KYMR($2.83B). KYMR YTD gains are higher at: 8.625 vs. CRSP (5.462). KYMR has higher annual earnings (EBITDA): -160.96M vs. CRSP (-313.08M). CRSP has more cash in the bank: 1.94B vs. KYMR (550M). KYMR has less debt than CRSP: KYMR (88.2M) vs CRSP (228M). CRSP has higher revenues than KYMR: CRSP (200M) vs KYMR (87.6M).
CRSPKYMRCRSP / KYMR
Capitalization3.54B2.83B125%
EBITDA-313.08M-160.96M195%
Gain YTD5.4628.62563%
P/E RatioN/AN/A-
Revenue200M87.6M228%
Total Cash1.94B550M352%
Total Debt228M88.2M259%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
82
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRSPKYMR
RSI
ODDS (%)
Bullish Trend 15 days ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 15 days ago
77%
Bullish Trend 15 days ago
84%
Momentum
ODDS (%)
Bullish Trend 15 days ago
76%
Bearish Trend 15 days ago
85%
MACD
ODDS (%)
Bullish Trend 15 days ago
72%
Bullish Trend 15 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 15 days ago
78%
Bullish Trend 15 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 15 days ago
86%
Bearish Trend 15 days ago
87%
Advances
ODDS (%)
Bullish Trend 21 days ago
81%
Bullish Trend 20 days ago
85%
Declines
ODDS (%)
Bearish Trend 15 days ago
84%
Bearish Trend 24 days ago
88%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 15 days ago
84%
Bearish Trend 15 days ago
84%
View a ticker or compare two or three
Ad is loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CHRSX20.460.24
+1.19%
Invesco Charter S
GIZRX12.710.14
+1.11%
Invesco Global Infrastructure R
AMRMX56.990.62
+1.10%
American Funds American Mutual A
RAPRX10.490.09
+0.87%
Cohen & Steers Real Assets R
TGWFX13.810.11
+0.80%
Transamerica Large Growth R4

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with CCCC. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+7.61%
CCCC - KYMR
60%
Loosely correlated
-2.28%
XENE - KYMR
50%
Loosely correlated
+1.19%
ERAS - KYMR
48%
Loosely correlated
+2.70%
CRSP - KYMR
48%
Loosely correlated
+2.42%
ACLX - KYMR
48%
Loosely correlated
+0.14%
More